AI for Medication Reconciliation & Drug Interaction Review

AI-Assisted Medication Review: Essence

When used in medication reconciliation, AI helps healthcare organizations establish a more complete medication history at transitions of care, reduce manual record comparisons, spot likely discrepancies, and surface clinically meaningful interaction risks for review before they occur. Custom AI solutions fit into existing EHR workflows and connect fragmented data sources into a structured record, avoiding the data-consistency and connectivity issues that often affect off-the-shelf AI suites. The goal is not autonomous clinical decision-making but a clearer, more structured review process — pharmacists and clinicians keep decision control while AI prepares the medication picture and surfaces the issues most likely to need attention.

Why Providers Are Turning to AI-Assisted Medication Review

Demand for AI-assisted medication review is driven by a persistent medication-harm problem, heavy pharmacist and clinician workload, and the difficulty of maintaining an accurate medication list across care settings. The World Health Organization estimates that medication-related harm costs about $42 billion globally each year. For many healthcare organizations, the push for AI adoption comes from the need to reduce reconciliation effort, improve medication-list accuracy, and focus safety review on high-risk issues — without adding extra steps for clinicians.

Reference Architecture for an Agentic AI Medication Reconciliation Solution

Below, INNERLUXES’ solution architects outline a cloud-agnostic, agentic reference architecture that works with a provider’s existing clinical systems. The organization keeps its core software (EHR, pharmacy) as systems of record; the AI solution adds an orchestration layer that gathers medication evidence, compares records across sources, and prepares reconciled findings for clinician review.

Data sources layer. The solution gathers medication-related evidence from the EHR and other hospital systems — medication histories, dispensing records, and supporting clinical context. A transition-of-care event (admission, transfer, discharge, or a relevant record update) starts reconciliation automatically, so clinicians do not have to trigger each step manually.

Agentic AI orchestration layer. An AI orchestrator manages the workflow and calls three specialized agents: a data-gathering agent collects medication history from all connected sources; a discrepancy-detection agent compares lists and flags conflicts, missing entries, and inconsistencies; and a clinical decision support agent prepares a reconciled list with recommendations for review. If evidence is incomplete, the workflow can loop back to data gathering before moving on. Collected data is mapped into a shared FHIR R4 layer and medications normalized with standard vocabularies such as RxNorm and NDC, so records from different sources compare consistently.

Human-in-the-loop interface. Pharmacists, nurses, and physicians review findings through an EHR-embedded UI, check AI recommendations and flagged medication issues, and decide what to accept, correct, or escalate. Each AI agent is kept focused on a narrow task so it can be tested, governed, and replaced independently — and limited by design to a specific set of allowed actions, minimizing the risk of AI overstepping its role.

Security and audit layer. A cross-cutting control spans the solution: it verifies every user through secure sign-in, enforces role-based access, and encrypts data in transit and at rest. It keeps an immutable audit trail of all important actions — data access, AI runs, recommendations, and final clinician decisions — and supports compliance with healthcare and data-protection requirements such as HIPAA, SOC 2, and GDPR.

Best Practices for Delivering AI-Assisted Medication Review

Start with one focused use case before scaling

A wide medication-intelligence initiative can affect too many clinical processes and systems at once, which makes it harder to approve, fund, and operationalize. Begin with a single high-value workflow — admission medication-history cleanup, discharge review support, or document-based medication intake. Design the data and integration foundation from the start so the solution can later expand to more medication-review capabilities.

Reuse existing EHR workflows through SMART on FHIR

To limit workflow disruption and speed up delivery, embed AI findings into the tools clinicians already use rather than building a separate application. Reuse existing EHR workflows through SMART on FHIR, surface recommendations in a pharmacist review queue, and integrate third-party medication-knowledge services instead of rebuilding drug databases. Add reconciliation as a modular layer so features can be released and iterated without destabilizing the core clinical systems.

Make “human-in-the-loop” explicit with safe UX and auditability

Adoption stalls when clinicians cannot see why a discrepancy or interaction was flagged, or worry about accountability. Use the solution as a decision-support assistant: present recommendations in a structured, reviewable format with supporting evidence and confidence cues, and support easy actions (accept, correct, reject, escalate). Every AI output should be traceable — data version, rules used, and the final human action — which is also the foundation for audits and validation.

Build a solid medication-data foundation first

Review quality depends directly on the quality of the medication data the system receives. If records come from different sources with inconsistent naming, missing instructions, or gaps between documented and dispensed medications, the solution will generate more noise, not better support. Extract details from structured records and unstructured documents, map them to a shared FHIR structure, normalize with RxNorm and NDC, and validate completeness and accuracy on a sample patient cohort before adding advanced review features.

Prioritize alerts to prevent alert fatigue

If the system treats every discrepancy or therapy risk equally, pharmacists and clinicians experience alert fatigue and start ignoring useful signals. Combine AI with deterministic rules, confidence scoring, and risk-based prioritization so high-risk items appear first while lower-priority findings go to a non-urgent queue. Mark low-confidence findings clearly, back them with source evidence, and monitor recommendation volumes to tune thresholds over time.

Design resilient integrations so one failure does not stop review

If the solution depends too heavily on one connection, interface failures or EHR downtime can delay reconciliation and reduce trust. Query each data source separately, save the records already collected, and show which source is still missing, so a case remains reviewable even when one source is temporarily unavailable. Retain discrepancies already identified and items already queued for review, and test interface failures, recovery, and EHR write-back in a sandbox before production.

Costs of an AI-Enabled Medication Review Solution

For a midsize healthcare organization, implementing an AI-enabled medication review solution typically ranges from $90,000+ for a narrowly scoped foundation or pilot to $600,000+ for an enterprise medication-intelligence platform.

A focused medication-reconciliation accelerator that extracts medications from selected documents, compares lists, flags likely discrepancies, and routes uncertain cases for review typically starts at $90,000+. A governed medication-safety layer that screens interactions, allergy conflicts, duplicate therapies, and dose/frequency issues with patient-specific logic and explainable evidence normally starts at $180,000+. An enterprise medication-intelligence platform that unifies data, reconciliation, safety screening, routing, analytics, and governance across care settings usually falls in the $350,000–$600,000+ range.

Key development cost drivers include:

• Integration scope and complexity: the number of connected source systems and supported exchange standards such as FHIR, HL7 v2, and NCPDP.
• Clinician review workflows: the complexity of review queues, exceptions, and EHR-embedded UI.
• Medication-safety logic depth: the amount of clinical rules and patient context (diagnoses, age, labs) considered during screening.
• Integrations: EHR, pharmacy, payer data, SSO, audit exports, and third-party medication-knowledge services.
• Workflow customization: the amount of tailoring needed to fit the solution into existing clinical and pharmacy workflows.
• MLOps and lifecycle controls: monitoring and alerts, explainability, versioning, threshold tuning, and release controls.
• Regulated workflow requirements (if applicable): audit trails, role-based access, traceability, validation-support features, and documentation.

Why INNERLUXES

• in custom software engineering, with experience building healthcare AI and clinical decision-support products.
• 132+ professionals on board, including AI consultants, data scientists, solution architects, software engineers, QA, DevOps, and compliance specialists.
• Hands-on experience with healthcare interoperability standards — HL7 v2/v3, FHIR, RxNorm, NDC, SNOMED CT, and LOINC.
• quality and information-security standards.
• Principal architects experienced in designing scalable healthcare product architectures, secure data exchange, and complex interoperability scenarios.
• Experience supporting compliance with HIPAA/HITECH, GDPR, FDA 21 CFR Part 11, and SOC 2.
• 68 projects delivered across 30+ industries, with project success no matter the constraints.